Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics

J. Nieto-Fontarigo (Santiago de Compostela, Spain), F. Salgado-Castro (Santiago de Compostela, Spain), M. San-José-Capilla (Santiago de Compostela, Spain), J. Carreira-Villamor (Santiago de Compostela, Spain), L. Valdés-Cuadrado (Santiago de Compostela, Spain), A. Faraldo-García (Santiago de Compostela, Spain), M. García-González (Santiago de Compostela, Spain), C. Diego-Roza (Ferrol, Spain), P. Martín-Lancharro (Santiago de Compostela, Spain), J. Moure-González (Santiago de Compostela, Spain), T. Liñares-Mata (Pontevedra, Spain), E. Takkouche-Souilamas (Santiago de Compostela, Spain), P. Arias (Santiago de Compostela, Spain), M. Nogueira (Santiago de Compostela, Spain), F. González-Barcala (Santiago de Compostela, Spain)

Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1649
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Nieto-Fontarigo (Santiago de Compostela, Spain), F. Salgado-Castro (Santiago de Compostela, Spain), M. San-José-Capilla (Santiago de Compostela, Spain), J. Carreira-Villamor (Santiago de Compostela, Spain), L. Valdés-Cuadrado (Santiago de Compostela, Spain), A. Faraldo-García (Santiago de Compostela, Spain), M. García-González (Santiago de Compostela, Spain), C. Diego-Roza (Ferrol, Spain), P. Martín-Lancharro (Santiago de Compostela, Spain), J. Moure-González (Santiago de Compostela, Spain), T. Liñares-Mata (Pontevedra, Spain), E. Takkouche-Souilamas (Santiago de Compostela, Spain), P. Arias (Santiago de Compostela, Spain), M. Nogueira (Santiago de Compostela, Spain), F. González-Barcala (Santiago de Compostela, Spain). Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics. 1649

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: